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1. Introduction 
Lactose is the main sugar in milk and therefore the main energy source for the newborn. 
Milk contains 4,8% lactose [1]. Lactose is a disaccharide consisting out of glucose and 
galactose.  
In normal physiological conditions lactose is hydrolyzed by lactase also known as lactase-
phlorizin hydrolase and under its systemic name lactose- galactosehydrolase (EC 3.2.1.108), 
which is a brush-border membrane bound enzyme. Glucose and galactose are taken up by 
the intestinal cells and transported into the bloodstream (Fig. 1). A considerable part of 
glucose and most galactose is cleared by the liver after the first pass. Lactose which is not 
hydrolyzed in the small intestine is passing into the colon where it is fermented. Lactose 
itself and its metabolites are osmotic active products causing an osmotic pressure; excessive 
amounts present in the colon are related to the development of clinical symptoms as 
diarrhea. 
The apparent lactase enzyme activity is affected by various factors like a. age, b. genetic 
background, c. integrity of the small intestinal membrane and d. the small-intestinal transit 
time 
a. The activity of the enzyme lactase is age dependent. The activity is high in the first year 
of age and declines until adulthood is reached. It is not clear what the physiological 
advantage is of the age dependency of the lactase activity in relation to the disaccharide 
glucose-galactose. 
Several remarkable aspects can be brought up in this respect: 
- Galactose has a higher hepatic clearance than glucose, which prevents a significant 
postprandial increase in blood glucose in the systemic circulation. 
- Galactose does not lead to an induction of the pancreatic insulin response. 
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- Lactase might have a variable and limited capacity which leads to a regulated spill over 
of lactose into the colon. There lactose might act as a primer (prebiotic) for the colonic 
microbiota in the first period of life (See also the subchapter of colonic fermentation of 
lactose). 
 
b. The role of the genetic background of the lactase activity has been described in detail 
elsewhere [2]. 
c. The lactase activity is strongly affected by the integrity of the small intestinal 
membrane. This is the reason why in patients with celiac disease, which have not been 
treated optimally, symptoms of lactose intolerance may appear [3]. 
d. Finally, the turnover of lactose by the enzyme is dependent on the small intestinal 
transit time (apparent enzyme activity). 
Fermented milk products can alleviate symptoms by delaying gastric emptying, orocecal 
transit time, or both. Delay of gastric emptying is due to the higher viscosity of the 
fermented milk product as compared to milk. Decrease of orocecal transit time is due to the 
metabolic products of probiotics or a lower osmotic force due to improved lactose digestion. 
A longer passage time in lactose maldigesters aids in hydrolyzing as much lactose as 
possible before spill over into the colon occurs. These findings support that pasteurized 
yogurt already provides alleviation of symptoms and that yogurt containing living 
probiotics improves this alleviation [4]. The effect of sugars, including lactose, on the small 
intestinal transit time is not well documented [5]. Changes in intestinal transit time due to 
the sugar molecules might especially play a role in other pathological conditions like 
irritable bowel disease. 
Lactose intolerance is the pathophysiological situation in which the small intestinal 
digestion and / or colonic fermentation is altered which leads to clinical symptoms. 
 
Figure 1. Small intestinal metabolism of lactose. Lactose enters the small intestine (1), lactose is then 
coverted by lactase from the host (2) or by probiotics (3). Excess amounts of lactose spill over into the 
colon (4). 
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2. Colonic fermentation of lactose 
Lactose which is spilled over into the colon can be hydrolyzed by the colonic bacterial 
enzyme β-galactosidase resulting in the formation of glucose and galactose. Glucose and 
galactose are subsequently converted into lactate as well as into the short chain fatty acids 
(SCFA) acetate, propionate and butyrate (see Fig. 2). Additionally, microbial biomass will be 
formed. The original substrate lactose, the intermediate products glucose and galactose and 
the final products can all contribute to the osmotic load in the colon. This might lead to 
increased colonic transit time, altered fermentation profiles and ultimately to diarrhea.  
The central question is which molecule contributes most to the pathological symptoms, like 
diarrhea: the original substrate lactose and / or one of the metabolites. 
As indicated in Fig. 2 the number of molecules is doubled after the first conversion by β-
galactosidase and tripled after the second conversion. A rapid conversion to the final 
metabolites enhances the osmotic force considerable.  
We first analyzed the role of lactose itself assuming that β-galactosidase is the rate limiting 
step. In a recent paper of us [6], we describe that inducing the colonic β-galactosidase by 
administration of yogurt and additional probiotics alleviates the clinical symptoms of 
lactose intolerance in an adult Chinese population. This suggests a specific role of lactose 
itself in the development of clinical symptoms. Our observation was confirmed by [7], who 
observed in post-weaning Balb/c mice that symptoms of diarrhea were reduced by inducing 
the β-galactosidase activity by administration of a recombinant Lactococcus lactis 
MG1363/FGZW strain expressing β-galactosidase. 
 
 
 
Figure 2. Colonic metabolism of lactose. Lactose enters the colon (1) and is fermented by the microbiota 
into glucose and galactose. Gasses such as hydrogen, methane and carbondioxide are formed (2). 
Lactate is also formed and converted into short chain fatty acids (SCFA)(3,4), also in this stage gasses 
are formed (2). These SCFAs can be taken up by epithelial cells (5) or can be used by the microbiota  
(6) or excreted in the faeces (7). 
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In contrast with these observations is the fact that β-galactosidase is an abundant enzyme in 
the colonic microbiota. It is present in many phylogroups of bacteria which in total might 
contribute to more than 40% of the total population of the colonic microbiome (Table 1). 
However, relative abundance and composition of bacteria with β-galactosidase in the distal 
colon do not seem to be related to lactose intolerance [8]. Another argument to consider is 
that the conversion of lactose into glucose, galactose and subsequently SCFA / lactate 
doubles and triples respectively the osmotic pressure. This aspect will be discussed in more 
detail under the chapter administration of pre- and probiotics. 
 
 
Table 1. Overview of all bacteria known to produce β-galactosidase. 
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Considering the physiological aspects of lactose digestion and fermentation it is clear that 
sufficient small intestinal hydrolysis of lactose related to the dose consumed will prevent 
symptoms of lactose intolerance. In case of relative insufficient lactase activity in the small 
intestine, spillover into the colon will occur. Adequate removal of osmotic active molecules, 
however, can prevent development of clinical symptoms of diarrhea. 
3. Clinical symptoms of lactose intolerance 
Symptoms of intestinal discomfort, abdominal pain and / or diarrhea can occur in case of 
lactose intolerance. These complaints are, however, not specific and can also be noticed in 
several other clinical conditions (for example irritable bowel syndrome, coeliac disease, 
Crohn’s disease). For proper treatment and correct interpretation of interventions accurate 
diagnosis of the underlying pathophysiology is therefore very important. 
4. Diagnostics of lactose intolerance 
The most direct diagnosis is the analysis of lactase activity. However, the enzyme activity 
derived from a small intestinal biopsy does not reflect the overall lactase activity in the small 
intestine because of the patchy character of the distribution of this enzyme. This can lead to 
false positive and negative estimation of the overall physiological capacity to hydrolyze 
lactose.  
Screening the genotype of people with lactose intolerant-like symptoms can aid in the 
correct diagnosis of lactose intolerance. The lactase gene can contain single-nucleotide 
polymorphisms (SNP) in the promotor region which leads to a high capacity to digest 
lactose. The most common SNP C/T-13910 is found in many Northwest European people. 
Several methods have been developed to detect this most common SNP. Järvelä et al. [2] 
sum up in their review the different methods for detection: minisequencing, enzyme 
digest, polymerase chain reaction-restriction fragment length polymorphism and 
pyrosequencing. For detection of all known SNPs, sequencing is the most reliable 
technique. Because there is a poor correlation between abdominal symptoms and lactase 
activity, genetics alone is not sufficient for a correct clinical diagnosis of adult lactose 
intolerance. 
For congenital lactase deficiency genetic screening is effective, mutations occur in the lactase 
gene itself and symptoms start shortly after birth [2]. The prevalence of this syndrome 
however, is very low. 
The analysis of the capacity to digest lactose in vivo by using two stable isotopes might be 
theoretically the best diagnostical method [9]. This test consists of the administration of 13C-
lactose and 2H-glucose and calculation of the ratio of the 13C-glucose/2H-glucose 
concentrations measured in plasma. This test can be used to analyze the effect of 
interventions and to demonstrate changes in the capacity to digest lactose. However, as 
a routinely used diagnostic tool this test is not applicable because of its complex 
character.  
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The most commonly used diagnostic method for lactose intolerance is the hydrogen breath 
test. This test is easy to apply in clinical practice, but as discussed in detail by us [12] others 
[11] this test leads to false positive and false negative results. 
A way to improve the precision of the breath test is to use 13C-lactose as a substrate and 
measure both H2 and 13CO2 in breath as first described by Hiele et al. [12]. This might be the 
best applicable test in daily practice. 
5. Application of pre- and probiotics to improve the clinical symptoms of 
lactose intolerance 
An effect of an intervention with probiotics can be expected at two levels: 
a. hydrolysis of lactose in the milk product and in the small intestine 
b. at the level of colonic fermentation 
a. The hydrolytic capacity of probiotic strains can be used to reduce the actual amount 
of lactose in the product, as occurs in yogurt. It can also be used to increase the 
overall hydrolytic capacity in the small intestine. The probiotic strain can be alive or 
can be lysed in the intestinal tract for its effect. Lactobacillus acidophilus is a bile-salt 
tolerant bacterium which hardly increases lactose digestion. However, sonication of 
Lactobacillus Acidophilus milk weakens their membranes and improves lactose-
intolerance symptoms [4]. Lactobacillus delbrüeckii in a milk product can deliver β-
galactosidase activity. These microorganisms do not have to be alive as long as their 
membranes are intact which helps to protect β-galactosidase during gastric passage 
[4]. Yogurt improves the lactose intolerance due to the presence of a group of 
lactobacillus bacteria it contains, i.e., Lactobacillus acidophilus [13]. Kinova et al. [14] 
described the beneficial effects of Lactobacillus present in fermented milk products. In 
[15] is described that consumption of yogurt containing Lactobacillus bulgaricus and 
Streptococcus thermophiles alleviate the lactose intolerance through their enzyme 
lactase when the product reaches the intestinal tract. Also Masood et al. [16] describe 
the beneficial effects of lactic acid bacteria in their review. From these findings it is 
inferred that lactose intolerance can be reduced by regularly consuming the 
fermented dairy products due to the production of β-galactosidase enzyme by lactic 
acid bacteria present in them.  
In general, it can be stated that in yogurt several probiotic strains are present which results 
in a better tolerance of lactose in lactose intolerant persons. 
b. Application of probiotics to manipulate the colonic fermentation.  
 
As suggested before [17], one of the problems in studies concerning this topic is that it is 
difficult to prove that the intervention only has an effect at the level of the colon and not at 
the level of the small intestine.  
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As discussed before it is not clear which compound, lactose or one of its fermentation 
metabolites contributes most to the development of symptoms of lactose intolerance. The 
hypothesis is that removal of these product(s) can reduce the clinical symptoms. 
1. Removal of lactose 
Lactose is hydrolyzed by β-galactosidase. We recently published [6] that a mix of probiotics 
in yogurt together with Bifidobacterium longum capsules could increase the β-galactosidase 
activity in faeces and alleviate the complaints of lactose intolerance. 
Together with the observation that the capacity to digest lactose, which was measured by 
the 13C-lactose/2H-glucose test, was not changed, it could be concluded that this 
intervention has an effect on colonic metabolism, possibly by enhancing the β-galactosidase 
activity. A study with mice [7] suggested the same mechanism. However, after analyzing 
the presence of β-galactosidase in the common bacterial strains in humans it can be 
concluded that β-galactosidase is abundantly present and it seems that administration of 
exogenous β-galactosidase from probiotics is not important. Alleviation of complaints and 
enhanced β-galactosidase concentration in stool therefore might have been a coincidence in 
our study. 
2. Removal of glucose and galactose 
Glucose is a preferred substrate for many bacterial strains and it is not likely that enhanced 
glucose removal by probiotic administration might play a role in alleviation of symptoms. 
Also galactose is easily consumed by most bacteria. Our in vitro studies [18] also indicated 
that accumulation of glucose and galactose does not occur during the breakdown of 
lactose, which confirms that these molecules once formed are subsequently metabolized 
very fast. 
3. Removal of acetate, propionate, butyrate and lactate 
As illustrated in Fig. 2 removal of SCFA takes place at the epithelium by uptake in the 
colonocytes and through the uptake and metabolism by various bacteria (“bacterial 
mass”). 
Uptake of SCFA into the epithelial cells is very effective because of co-transport of fluid 
which reduces the osmotic force [19]. The maximal epithelial uptake rate is not known and it 
is not known if this varies in persons with hypolactasia with and without symptoms after 
lactose consumption.  
Another major way by which SCFA are removed is via the uptake and metabolism by 
bacteria. SCFA serve as a carbon and energy source for the anaerobic bacteria and this may 
increase the “bacterial mass”. In the presence of sulphate, lactate may be metabolized by 
sulphate-reducing bacteria, producing toxic sulphide as byproduct [20]. On the other hand 
lactate together with acetate can be converted by different groups of bacteria into butyrate; 
for instance by bacteria such as Eubacterium hallii and Anaerostipes cacca [21]. Butyrate is 
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thought to be beneficial for colonic health. Also Bacteroides several subspecies are capable 
of metabolizing lactate, but produce propionate. The metabolism of intermediates like 
lactate and acetate are an important step in the breakdown of sugars by gut bacteria [22]. 
For gut health it is important that from lactate a balanced mixture of SCFA are formed 
and for this correct conditions should be present. The hypothesis that for the prevention 
of diabetes type 1 butyrate production is preferred over propionate production is stated 
by [23]. They stated  this because butyrate production enforces the barrier function of the 
gut. Therefore, conditions that stimulates these metabolic associations should be enforced. 
This implies that a mixture of pro- and prebiotics as occurs in yogurt might be an efficient 
approach, since it favors acetate and lactate formation, and in this way stimulate butyrate 
formation. If lactate removal via for instance butyrate production, does not occur this may 
impact functioning of the epithelium. It then can be speculated that an impaired epithelial 
function will hamper the uptake of lactate, and causes an increased osmotic pressure in 
the gut.  
Several other studies have reported the beneficial effect of a probiotic intervention on 
symptoms of lactose intolerance but without describing a precise mechanism. In some of 
these studies the observation that the specific strains under study survive the small 
intestinal passage is used as an argument that the effect occurs at the colonic level. 
The combination of Lactobacillus casei Shirota and Bifidobacterium breve Yakult has been 
shown to survive gastrointestinal transit and to improve symptoms of lactose intolerance. 
This effect persists after the intervention is ceased [24]. Other probiotic strains have shown 
beneficial effects on lactose digestion and symptoms in lactase deficient persons [12,25,26]. 
Further investigation with different strains of bifidobacteria or lactobacilli on symptoms of 
lactose intolerance showed contradictory results. [27] observed that 7 day 
supplementation with Lactobacillus acidophilus did not change hydrogen production or 
symptoms. [28] however found a decrease in hydrogen production after 7 days of milk 
intake supplemented with Lactobacillus acidophilus, but not all individuals had relief of 
their symptoms. Bifidobacterium breve for 5 days did not improve lactose intolerance 
symptoms, but reduction in breath hydrogen was measured [29]. Overall these 
contradictions have not led to a general acceptance of probiotics as a efficient treatment 
for lactose intolerance [30-32]. 
 
The observation of adaptation seen in lactose intolerant persons consuming regularly small 
amounts of dairy products might be in accordance with the concept of adaptation of the 
colonic metabolism by increased lactate metabolizing populations in the gut. This allows 
efficient metabolism of increased amounts of lactose [33]. The observation that lactulose 
fermentation is impaired during ingestion of ampicillin (2g / day) gives rise to the idea that 
antibiotics can disrupt the microbiota in the colon. There is no evidence in the literature that 
antibiotics have a negative effect on the fermentation of lactose, however it would not be 
surprising if such a phenomenon was found [34]. 
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6. Conclusion 
There is evidence that probiotics can alleviate symptoms of lactose intolerance. This can 
occur by increased hydrolysis of lactose in the dairy  product and in the small intestine. It 
can also be achieved by manipulation of the colonic metabolism. However, the precise 
mechanism how colonic metabolism influences lactose intolerance symptoms is not yet 
known. The reported studies are not consistent in their experimental set-up, results and 
conclusions. 
The diagnosis of lactose maldigestion and the relation to complaints is highly complex. For 
an effective treatment of lactose intolerance and a correct interpretation of the effects of an  
intervention, knowledge of the underlying mechanisms of lactose intolerance is essential. 
Development of new strategies concerning the treatment with probiotics should therefore 
include an analysis of the relevant intermediate endpoints. In this way applications of 
probiotics for treatment of lactose intolerance could lead to a promising strategy. 
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